XML 39 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity - USD ($)
Series A Convertible Preferred Stock
Preferred Stock
Series A Convertible Preferred Stock
Common Stock
ATM offering
Common Stock
Additional Paid-in capital
ATM offering
Additional Paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
ATM offering
Total
Temporary equity, beginning balance (in shares) at Dec. 31, 2022 56,227                  
Temporary equity, beginning balance at Dec. 31, 2022 $ 1,311,063                  
Temporary equity, ending balance (in shares) at Dec. 31, 2023 56,227 56,227                
Temporary equity, ending balance at Dec. 31, 2023 $ 1,311,063 $ 1,311,063                
Equity, beginning balance at Dec. 31, 2022       $ 2,655   $ 330,060,836 $ (10,623,408) $ (293,796,405)   $ 25,643,678
Equity, beginning balance (in shares) at Dec. 31, 2022       2,655,269            
Increase (Decrease) in Stockholders' Equity                    
Vesting of restricted stock units       $ 5   (5)        
Vesting of restricted stock units (in shares)       5,102            
Issuance of common stock, net     $ 26 $ 1,050 $ 268,099 4,870,815     $ 268,125 4,871,865
Issuance of common stock, net (in shares)     26,302 1,050,000            
Stock-based compensation           444,459       444,459
Foreign currency translation             12,135     12,135
Net Income (Loss)               (14,286,756)   (14,286,756)
Equity, ending balance at Dec. 31, 2023       $ 3,736   335,644,204 (10,611,273) (308,083,161)   16,953,506
Equity, ending balance (in shares) at Dec. 31, 2023       3,736,673            
Temporary equity, ending balance (in shares) at Dec. 31, 2024 56,227 56,227                
Temporary equity, ending balance at Dec. 31, 2024 $ 1,311,063 $ 1,311,063                
Increase (Decrease) in Stockholders' Equity                    
Vesting of restricted stock units       $ 11   (11)        
Vesting of restricted stock units (in shares)       10,518            
Issuance of common stock, net     $ 41 $ 1,688 $ 134,364 14,685,802     $ 134,405 14,687,490
Issuance of common stock, net (in shares)     41,152 1,687,712            
Issuance of common stock to consultant       $ 5   17,430       17,435
Issuance of common stock to consultant (in shares)       5,000            
Stock-based compensation           489,436       489,436
Foreign currency translation             (16,106)     (16,106)
Net Income (Loss)               (12,958,711)   (12,958,711)
Equity, ending balance at Dec. 31, 2024       $ 5,481   $ 350,971,225 $ (10,627,379) $ (321,041,872)   $ 19,307,455
Equity, ending balance (in shares) at Dec. 31, 2024       5,481,055